Here is the genuine answer: VIP will not be a standard-objective anti-inflammatory peptide you are able to substitute into any protocol anticipating wide immune suppression. Its effects are receptor-specific, tissue-dependent, and timing-delicate in ways that make protocol structure significantly much more complicated than merely dosing and measuri